Lantern Pharma Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Lantern Pharma Inc. reported Cash And Cash Equivalents At Carrying Value of $4.42 million for the year ending 2025.

  • Lantern Pharma Inc. showed a decrease of -41.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Lantern Pharma Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Lantern Pharma Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 893.5%.
  • Historical annual values: Fiscal year 2025: $4.42 million | Fiscal year 2024: $7.51 million | Fiscal year 2023: $21.94 million | Fiscal year 2022: $37.20 million | Fiscal year 2021: $51.52 million | Fiscal year 2020: $19.23 million | Fiscal year 2019: $1.23 million | Fiscal year 2018: $445.2 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: